Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition compared with methylphenidate

CONCLUSIONS: These findings suggest that synergistic effects may emerge from the coadministration of selective agents (e.g., α(2A) and D(1) agonists) and should be considered for further study, especially as regards individuals with decrements in cognitive function.

via https://pubmed.ncbi.nlm.nih.gov/41646286/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260217010907&v=2.18.0.post22+67771e2